IP Verse

Methods And Compounds For Increasing Sensitivity Of Botulinum Assays - EP2800973

The patent EP2800973 was granted to Biomadison on May 16, 2018. The application was originally filed on Jan 3, 2013 under application number EP13733838A. The patent is currently recorded with a legal status of "Revoked".

EP2800973

BIOMADISON
Application Number
EP13733838A
Filing Date
Jan 3, 2013
Status
Revoked
Nov 20, 2023
Publication Date
May 16, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MERZ PHARMAFeb 15, 2019ALTMANN STOSSEL DICK PATENTANWALTE PARTG MBBADMISSIBLE

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2006134722
DESCRIPTIONWO2009035476
DESCRIPTIONWO2009114748
INTERNATIONAL-SEARCH-REPORTUS2006134722
INTERNATIONAL-SEARCH-REPORTUS2009076019
INTERNATIONAL-SEARCH-REPORTUS2010278745
INTERNATIONAL-SEARCH-REPORTUS2011033866
INTERNATIONAL-SEARCH-REPORTWO2009114748
INTERNATIONAL-SEARCH-REPORTWO2010090677
OPPOSITIONUS2006134722
OPPOSITIONUS2009191583
OPPOSITIONUS2010278745
OPPOSITIONWO2007001358
OPPOSITIONWO2009035476
OPPOSITIONWO2009114748
OPPOSITIONWO2012166943
SEARCHWO2009035476
SEARCHWO2009114748
SEARCHWO2012166943

Non-Patent Literature (NPL) Citations (21) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- CLAUDE BERNEY; GAUDENZ DANUSER, "FRET or No FRET: A Quantitative Comparison", Biophys J., (20030600), vol. 84, no. 6, pages 3992 - 4010
DESCRIPTION- DAWSON, Plant Mol. Biol., (19930000), vol. 23, page 97
DESCRIPTION- FOSTER; STRINGER, "Genetic Regulatory Elements Introduced Into Neural Stem and Progenitor Cell Populations", Brain Pathology, (19990000), vol. 9, pages 547 - 567, XP000997670
DESCRIPTION- KOHL et al., "99", Proc. Nat'l. Acad. Sci., (20020000), page 12161
DESCRIPTION- SLEAT, Gene, (19870000), vol. 217, pages 217 - 225
EXAMINATION- Anonymous, "B-27 Serum-Free Supplement (50X) liquid | Thermo Fisher Scientific", ThermoFischer Scientificc Website, (20160613), URL: https://www.thermofisher.com/nl/en/home/technical-resources/media-formulation.250.html, (20160613), XP055279982
INTERNATIONAL-SEARCH-REPORT- RUGE, DANIEL R. ET AL., "Detection of six serotypes of botulinum neurotoxin using fluorogenic reporters.", ANALYTICAL BIOCHEMISTRY, NEW YORK, (20110104), pages 200 - 209, XP002672446
OPPOSITION- LEDEEN et al., "The Role of GM1 and Other Gangliosides in Neuronal Differentiation Overview and New Findings", Annals of the New York Academy of Sciences, (19980000), vol. 845, pages 161 - 175
OPPOSITION- SABINE PELLETT, "Progress in cell based assays for botulinum neurotoxin detection.", NIH Public Access Author Manuscript, (20130506), vol. 364, pages 1 - 26, XP055111189
OPPOSITION- PARODI et al., "Morphological change and cellular differentiation induced by cisplatin in human neuroblastoma cell lines", Cancer Chemother. Pharmacol., (19890000), vol. 25, pages 114 - 116, XP055574166
OPPOSITION- SIDELL et al., "Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines", Exp. Cell Res., (19830000), vol. 148, no. 1, pages 21 - 30, XP024856548
OPPOSITION- PONZONI et al., "Morphologic and phenotypic changes of human neuroblastoma cells in culture induced by cytosine arabinoside", Exp. Cell Res., (19890000), vol. 181, pages 226 - 237, XP024854940
OPPOSITION- PARODI et al., "Effects of γ-interferon on the growth, morphology, and membrane and cytoskeletal proteins expression of LAN-1 cells", Exp. Cell Res., (19891200), vol. 185, no. 2, pages 327 - 341, XP024854981
OPPOSITION- MINANA et al., "Inhibition of protein kinase C induces differentiation of neuroblastoma cells", FEBS Lett, (19890000), vol. 255, pages 184 - 186, XP025575979
OPPOSITION- PARODI et al., "The specific inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7), induces morphological change and cell differentiation of human neural crest-derived cell lineages", FEBS Lett, (19900000), vol. 269, pages 4 - 6, XP025605127
OPPOSITION- IDO et al., "An inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine(H-7) inhibits TPA-induced reduction of vincristine uptake from P388 murine leukemic cell", Leukemia Res, (19860000), vol. 10, no. 9, pages 1063 - 1069, XP022920362
OPPOSITION- RUGE et al., "Detection of six serotypes of botulinum neurotoxin using fluorogenic reporters", Anal. Biochem., (20110000), vol. 411, pages 200 - 209, XP002672446
OPPOSITION- WHITEMARSH et al., "Model for studying Clostridium botulinum neurotoxin using differentiated motor neuron-like NG 108-1 5 cells", Toxicol. Sci., (20120400), vol. 126, no. 2, pages 426 - 35, XP055574161
OPPOSITION- DONG et al., "Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells", PNAS, (20040000), vol. 101, no. 41, pages 14701 - 14706, XP008156528
OPPOSITION- FERNANDEZ-SALAS et al., "Botulinum Neurotoxin Serotype a Specific Cell-Based Potency Assay to Replace the Mouse Bioassay", PLoS One, (20120000), vol. 7, pages 1 - 13, XP055070996
OPPOSITION- HAN et al., "Proteomics Analysis of the Expression of Neurogranin in Murine Neuro- blastoma (Neuro-2a) Cells Reveals Its Involvement for Cell Differentiation", Int J Biol Sci., (20070419), vol. 3, no. 5, pages 263 - 73, XP055574184

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents